VintaBio
Signal active
Organization
Contact Information
Overview
VintaBio offers cell and gene therapy manufacturing services to pharmaceutical and biotechnology organizations. VintaBio is a life sciences business with unparalleled industry knowledge that is assisting in the alleviation of the viral vector bottleneck in cell and gene therapy development.
About
Industries
Biotechnology, Pharmaceutical, Therapeutics
Founded
2020
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
VintaBio headquartered in United States, North America, operates in the Biotechnology, Pharmaceutical, Therapeutics sector. The company focuses on Biotechnology and has secured $768.0M in funding across 12 round(s). With a team of 11-50 employees, VintaBio is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - VintaBio, raised $64.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
1
Lead Investors
0
Total Funding Amount
$64.0M
Details
0
VintaBio has raised a total of $64.0M in funding over 0 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|
Investors
VintaBio is funded by 3 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Min Cui | - | FUNDING ROUND - Min Cui | 64.0M |
| VintaBio | - | FUNDING ROUND - VintaBio | 64.0M |
| Decheng Capital | - | FUNDING ROUND - Decheng Capital | 64.0M |
Recent Activity
There is no recent news or activity for this profile.